MONOGRAPH LIBRARY
5-Amino-1-methylquinolinium iodide (5-amino-1MQ) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), the enzyme that methylates nicotinamide using S-adenosylmethionine (SAM) as a methyl donor. Two metabolic problems flow from…
Failed Drug Candidate With Misleading GRAS Status
Innate Repair Receptor Agonist in Phase 2 Development
Emerging Peptide for Tissue Repair Research
Cartalax (Ala-Glu-Asp, AED tripeptide) is one of approximately fifteen short-peptide bioregulators developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology beginning in the 1970s. The Khavinson…
Cerebrolysin is a parenteral pharmaceutical preparation of low-molecular-weight peptides and free amino acids derived from enzymatically processed porcine brain tissue. Manufactured by EVER Pharma since the 1970s, it is approved in more than 40…
Long-Acting GHRH Analog for GH Secretion Research
Angiotensin IV Analog With No Human Safety Data
Delta sleep-inducing peptide (DSIP) is a small (nine amino acid) neuropeptide first identified in 1977 by Monnier and colleagues in Switzerland, isolated from the cerebral venous blood of rabbits exposed to electrical stimulation that induced…
Unproven Telomerase Activator From Russia
Follistatin is a glycoprotein that binds and neutralizes myostatin (GDF-8), activin A, and several bone morphogenetic proteins. Because myostatin is the dominant brake on skeletal-muscle growth, blocking myostatin produces dramatic muscle…
Cosmetic Peptide With Topical Benefits and Injectable Research Status
Hexarelin is a synthetic hexapeptide growth hormone-releasing peptide (GHRP) developed in the early 1990s as part of the GHRP-2/GHRP-6/hexarelin family. At equivalent doses, hexarelin produces growth hormone pulses larger than GHRP-2 or GHRP-6,…
Potent Modified IGF-1 With Extreme Abuse Potential
Selective GH Secretagogue for Research Use
Investigational Reproductive Peptide in Active Research
Tripeptide Fragment With Zero Human Evidence
Human Cathelicidin Antimicrobial Peptide (Preclinical Only)
Preclinical Mitochondrial Peptide With Theoretical Metabolic Benefits
Semax (a synthetic analog of the N-terminal fragment of ACTH 4-10) and Selank (a synthetic analog of tuftsin) were developed by Russian scientific research institutes beginning in the 1980s-1990s. Both are registered medications in Russia for…
Pinealon (Glu-Asp-Arg) is a synthetic tripeptide developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It is part of the broader Khavinson 'short peptide' bioregulator program, which has…
FDA-Approved Melanocortin Agonist (Women Only)
Russian-Approved Anxiolytic Peptide (Tuftsin Analog)
Russian-Approved Neuroprotective Peptide (ACTH Analog)
FDA-Approved GHRH Analog (Discontinued Commercially, Available via Compounding)
Investigational Mitochondrial Protective Peptide in Active Development
Actin-Binding Peptide Under Scrutiny
FDA-Approved GHRH Analog for HIV-Associated Lipodystrophy
Approved in 35+ Countries (Except US, EU, UK, Australia, Canada)
Endogenous Neuropeptide With Limited Clinical Evidence for CIRS
Bug report, content request, or general comment — we read everything.